Clinical Factors Affecting Survival in Patients with Congenitally Corrected Transposition of the Great Arteries: A

Sonia Alicja Nartowicz1, Ewelina Jakielska1, Piotr Ratajczak2

  • 11st Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

PubMed

Insights

Congenitally corrected transposition of the great arteries (cc-TGA) patients face mortality risks from heart failure and systemic ventricle dysfunction. For those operated on, systemic ventricle dysfunction and moderate systemic valve regurgitation are key survival factors.

Area of Science:

  • Cardiology
  • Congenital Heart Disease Research

Background:

  • Congenitally corrected transposition of the great arteries (cc-TGA) involves complex heart defects.
  • Many cc-TGA patients have co-existing conditions requiring intervention.
  • Surgical or physiological repair allows most cc-TGA patients to reach adulthood.

Purpose of the Study:

  • To identify mortality risk factors in patients with cc-TGA.
  • To analyze long-term survival predictors in this population.

Main Methods:

  • Systematic review of 10 retrospective cohort studies from PubMed.
  • Inclusion criteria: cc-TGA patients, ≥5-year follow-up, cardiovascular death endpoint ≥30 days post-surgery.
  • Analysis of 532 patients, with 83 experiencing cardiovascular death.

Main Results:

  • Overall cc-TGA mortality risk factors: NYHA class ≥III/heart failure hospitalization (OR=10.53) and systemic ventricle dysfunction (SVD) (OR=4.95).
  • No significant long-term survival impact found for supraventricular arrhythmia, moderate or severe systemic valve regurgitation (SVR), or pacemaker implantation.
  • In operated patients, SVD (OR=4.69) and SVR ≥moderate (OR=3.85) significantly impacted survival.

Conclusions:

  • NYHA class ≥III/heart failure hospitalization and SVD are primary long-term mortality risks for all cc-TGA patients.
  • For cc-TGA patients who underwent surgery, SVD and moderate-to-severe SVR are significant predictors of survival.